Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
Stratified by different indications For indication of obesity alone, AOMs resulted in 1.31 kg (95% CI 0.38 to 2.24, P = 0.006, I 2 = 73%) weight regain compared with control groups
New research shows promising results for adults with type 1 diabetes, with patients losing an average of 18.5 pounds over six months while improving blood sugar control
Semaglutide should not be used for the treatment of type 1 diabetes mellitus
Semaglutide: A Complete Comparison Guide Tirzepatide and semaglutide are both once-weekly injections that support weight loss and metabolic health, but they work in slightly different ways
Abbreviations: DXA, dual-energy X-ray absorptiometry